Авторы

  • Hilolaxon Mamadaliyeva
    Andijon Davlat tibbiyot instituti

DOI:

https://doi.org/10.71337/inlibrary.uz.journal-science-innovative.81916

Ключевые слова:

Hemorrhagic vasculitis nephropathy children immunology hematology prevention immune response

Аннотация

Hemorrhagic vasculitis is a systemic disease that often affects children and may cause complications such as nephropathy. The immune and hematological systems play an important role in the development and severity of this condition. This study investigates immuno-hematological characteristics in children with nephropathic forms of hemorrhagic vasculitis and offers strategies to improve prevention and management. Our results show the significance of early diagnosis and individualized preventive measures.


background image

“JOURNAL OF SCIENCE-INNOVATIVE RESEARCH IN

UZBEKISTAN” JURNALI

VOLUME 3, ISSUE 04, 2025. APRIL

ResearchBib Impact Factor: 9.654/2024 ISSN 2992-8869

439




Immuno-hematological features of the course of hemorrhagic vasculitis in

children with nephropathy and improvement of prevention

Иммуно-гематологические особенности течения геморрагических

васкулитов у детей с нефропатией и совершенствование профилактики

Болаларда геморрагик васкулитни нефропатия билан кечишининг

иммун-гематологик хусусиятлари ва унинг профилактикасини

такомиллаштириш

Mamadaliyeva Hilolaxon Olimjon qizi

Andijon Davlat tibbiyot instituti

Abstract

Hemorrhagic vasculitis is a systemic disease that often affects children and

may cause complications such as nephropathy. The immune and hematological
systems play an important role in the development and severity of this condition.
This study investigates immuno-hematological characteristics in children with
nephropathic forms of hemorrhagic vasculitis and offers strategies to improve
prevention and management. Our results show the significance of early diagnosis
and individualized preventive measures.

Keywords:

Hemorrhagic vasculitis, nephropathy, children, immunology,

hematology, prevention, immune response

Аннотация

Геморрагический васкулит — это системное заболевание, часто

встречающееся у детей и сопровождающееся осложнениями, такими как
нефропатия. Иммунная и гематологическая системы играют важную роль в
развитии

и

тяжести

заболевания.

В

статье

рассматриваются

иммуногематологические особенности у детей с нефропатической формой
геморрагического

васкулита,

а

также

предложены

меры

по

совершенствованию профилактики и лечения. Результаты подтверждают
важность ранней диагностики и индивидуального подхода.

Ключевые слова:

Геморрагический васкулит, нефропатия, дети,

иммунология, гематология, профилактика, иммунный ответ


background image

“JOURNAL OF SCIENCE-INNOVATIVE RESEARCH IN

UZBEKISTAN” JURNALI

VOLUME 3, ISSUE 04, 2025. APRIL

ResearchBib Impact Factor: 9.654/2024 ISSN 2992-8869

440




Annotatsiya

Gemorragik vaskulit — bu bolalarda tez-tez uchraydigan va nefropatiya kabi

asoratlar bilan kechadigan tizimli kasallikdir. Immun va gematologik tizimlar bu
kasallikning rivojlanishi va og‘irligida muhim rol o‘ynaydi. Ushbu maqolada
bolalarda nefropatiya bilan kechayotgan gemorragik vaskulitning immun-
gematologik xususiyatlari o‘rganildi hamda profilaktikani yaxshilash strategiyalari
taklif qilindi. Natijalar erta tashxis va individual yondashuv muhimligini ko‘rsatdi.

Kalit so‘zlar:

Gemorragik vaskulit, nefropatiya, bolalar, immunologiya,

gematologiya, profilaktika, immun javob



Introduction

Hemorrhagic vasculitis, also called Henoch-Schönlein purpura (HSP), is the

most common type of systemic vasculitis found in children. This condition affects
small blood vessels, leading to inflammation and bleeding under the skin, into the
joints, digestive organs, and kidneys (Saulsbury, 2007). While most children
experience a mild form of the disease, complications may arise when the kidneys
are involved. In such cases, there is a higher risk of serious health problems,
including the possible development of chronic kidney disease (CKD).

Children who develop nephropathy due to HSP often require long-term

medical care and specialized treatment. The immune system plays a key role in this
process by forming immune complexes that damage blood vessels and kidney
tissues. Hematological markers, such as white blood cell and platelet counts, are
useful in evaluating inflammation and predicting complications. For this reason,
studying immuno-hematological features in children with nephropathy is important.
It can improve early diagnosis, help reduce long-term effects, and contribute to better
preventive care.

Methods

This study involved 52 children between the ages of 4 and 12 diagnosed with

hemorrhagic vasculitis. Out of this group, 20 children showed signs of nephropathy,
while 32 did not. All participants underwent detailed clinical examinations and
laboratory testing. Laboratory assessments included a complete blood count (CBC),
erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), levels of
immunoglobulins A and G (IgA, IgG), and components of the complement system


background image

“JOURNAL OF SCIENCE-INNOVATIVE RESEARCH IN

UZBEKISTAN” JURNALI

VOLUME 3, ISSUE 04, 2025. APRIL

ResearchBib Impact Factor: 9.654/2024 ISSN 2992-8869

441




(C3 and C4). Urinalysis and serum creatinine levels were checked to determine
kidney involvement.

The children were monitored for six months, and the effectiveness of their

treatment was evaluated. The study aimed to find links between immune and
hematological markers and the development of nephropathy, and to suggest ways to
improve prevention and management of the disease.

Results

Our findings showed that immune system changes were more frequent in

children who had nephropathy. These children had notably higher IgA levels
(p<0.05), which supports the idea that immune complex deposits contribute to
kidney damage (Davin & Weening, 2003). Additionally, lower levels of C3
complement were observed, indicating activation of the immune response.

Hematological results revealed increased leukocyte and platelet counts in the

nephropathy group, reflecting inflammation and immune activity. ESR and CRP
levels were also significantly higher, showing that the disease was more active. In
some patients, symptoms such as microscopic hematuria and proteinuria lasted more
than three months, raising the risk of developing chronic kidney problems.

Clinically, children with nephropathy experienced more frequent disease

relapses and slower recovery times. Treatment with corticosteroids helped reduce
kidney symptoms and improve health outcomes. Early administration of anti-
inflammatory and immune-modulating therapy was found to be effective in
managing the condition.

Discussion

The results of this study confirm that immune and hematological factors

significantly influence the course of hemorrhagic vasculitis, especially when kidney
involvement is present. Higher IgA levels suggest that immune reactions contribute
directly to kidney damage. The decrease in complement proteins, particularly C3,
also supports this immune-mediated mechanism (Narchi, 2005).

Routine monitoring of blood markers may help identify children at greater

risk in the early stages of the disease. This allows doctors to begin treatment earlier
and avoid complications. Preventive measures should include minimizing exposure
to infections and stress, which are common triggers for disease flare-ups. Parents
and caregivers must also be informed about early warning signs such as skin rashes,
stomach pain, or dark-colored urine.


background image

“JOURNAL OF SCIENCE-INNOVATIVE RESEARCH IN

UZBEKISTAN” JURNALI

VOLUME 3, ISSUE 04, 2025. APRIL

ResearchBib Impact Factor: 9.654/2024 ISSN 2992-8869

442




Individual treatment plans based on each child’s immune and blood profile

may lead to better results. Such a personalized approach can improve the child’s
quality of life and lower the chance of developing long-term health issues.

Conclusion

Hemorrhagic vasculitis in children, particularly when accompanied by

nephropathy, requires close attention to the immune system and blood-related
indicators. Early diagnosis, regular check-ups, and customized treatment plans can
improve patient outcomes and reduce the risk of chronic kidney disease. Prevention
should focus on education, timely screening, and targeted care for children at risk.
Continued research is necessary to create more effective prevention strategies based
on immune system profiles.

References

Davin, J. C., & Weening, J. J. (2003). Henoch–Schönlein purpura nephritis: an
update.

European

Journal

of

Pediatrics

,

162(6),

451–456.

https://doi.org/10.1007/s00431-003-1193-4

Narchi, H. (2005). Risk of long term renal impairment and duration of follow up
recommended for Henoch-Schönlein purpura with normal or minimal urinary
findings: a systematic review.

Archives of Disease in Childhood

, 90(9), 916–920.

https://doi.org/10.1136/adc.2004.068718

Saulsbury, F. T. (2007). Clinical update: Henoch–Schönlein purpura.

The Lancet

,

369(9566), 976–978.

https://doi.org/10.1016/S0140-6736(07)60474-3


Библиографические ссылки

Davin, J. C., & Weening, J. J. (2003). Henoch–Schönlein purpura nephritis: an update. European Journal of Pediatrics, 162(6), 451–456. https://doi.org/10.1007/s00431-003-1193-4

Narchi, H. (2005). Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review. Archives of Disease in Childhood, 90(9), 916–920. https://doi.org/10.1136/adc.2004.068718

Saulsbury, F. T. (2007). Clinical update: Henoch–Schönlein purpura. The Lancet, 369(9566), 976–978. https://doi.org/10.1016/S0140-6736(07)60474-3